Biofilms
Unresolved yeast or bacterial dysbiosis
Treatment of biofilm is an important new strategy in enhancing development for children with autism. When children improve on anti-microbial protocols, it is important to consider biofilm as a factor in treatment.
Biofilm occurs when these microbes link together. The connections between microbes are very difficult to break down and account for some of the mucous that occurs during a kill protocol. Biofllms are technically a polysaccharide-type matrix (mucous) secreted by bacteria and yeast. These pathogens create a biofilm to defend against the host’s immune system.
Opportunistic bacteria and yeast secrete toxins. These toxins can contribute to behavioural issues, digestive concerns and impair development.
An example of biofilms is dental cavities. Bacteria in the mouth can produce biofilms which lead to cavity formation.
Biofilms can effect children with ASD and other developmental concerns in the following ways:
- Improve when placed on antibiotics or antifungal medication
- Aggression, agitation, head-banging and others behaviours
- Obsessive-Compulsive Disorder (OCD), perseverative and/or repetitive behaviors
- Children who get worse in the spring and/or fall
- Persistent and unresolved yeast and/or bacteria as evidenced on Organic Acid Test from Great Plains Laboratory (such as arabinose for yeast or HPHPA for clostridia bacteria
A biofilm protocol was designed by Anju Usman, M.D. It has 3 stages:
- Breaking down the biofilm
- Attacking of the microbes
- Cleaning-up phase
Parents whose children have undergone treatment to break down biofilms in the digestive tract describe bowel movements with copious amounts of mucous. Once the mucous is passed, dramatic shifts in development can be seen.
Research supports a connection between the digestive tract and development. Microbes in the gut can change the way the body functions. Identifying and treating biofilms is an important strategy in biomedical treatment of autism spectrum disorder, AD/HD and other developmental concerns.